Treatment of Genitourinary Cancers
Treatment of localized genitourinary cancers often includes surgery and/or radiation therapy. Mount Sinai is among the pioneers of minimally invasive surgery, including robotic surgery for the treatment of prostate cancer and other cancers of the genitourinary tract.
Mount Sinai has developed techniques for the precise delivery of radiation therapy for prostate cancer that are currently used all over the world. These efforts have resulted in treatments that not only are more effective in treating cancer, but also allow faster recovery times and fewer side effects.
For our patients with more advanced cancers, our medical oncologists are experts in the use of systemic treatments, such as chemotherapy and hormonal therapy, and have been instrumental in developing many of the standard treatments used today.
Each of these therapies is individualized for your particular set of circumstances.
As a Mount Sinai genitourinary cancer patient, you may have the opportunity to participate in a research study on your specific type of cancer. Through these studies (clinical trials), you may receive a promising new genitourinary cancer therapy not otherwise available. Your participation in a clinical trial is completely voluntary, but is one of the benefits extended to Mount Sinai patients.
For a list of currently open clinical trials, please see Clinical Trials and Research Studies at Mount Sinai.
Support for patients and caregivers
We are dedicated to providing the best care to patients with genitourinary cancers and their loved ones. This includes compassionate nursing, nutritional consultations, counseling services, and support groups. For more information on these services, please see Social Work Services or contact The Derald H. Ruttenberg Treatment Center at 212-241-6756.
Tel: 800-MD-SINAI (800-637-4624)